Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility

Maurizio Genuardi, Alessaffdra Viel, Daniela Bonora, Eugenia Capozzi, Alfonso Bellacosa, Francesca Leonardi, Roberta Valle, Andrea Ventura, Monica Pedroni, Mauro Boiocchi, Giovanni Neri

Research output: Contribution to journalArticle

Abstract

The phenomenon of alternative splicing in the DNA mismatch repair genes MLH1 and MSH2 was extensively investigated by coupled reverse transcription-polymerase chain reaction in different human tissues, including 42 mononuclear blood cell samples - 31 obtained from familial colon cancer patients or their at-risk relatives and 11 from healthy blood donors - 7 normal colonic mucosae, 4 established human cancer cell lines, 8 colorectal tumors, and one sample each of ileum, liver, muscle, thymus, breast, and EBV-transformed lymphoblasts. Several isoforms were observed for each gene. Products of MLH1 alternative splicing included mRNAs lacking alternative exons 6/9, 9, 9/10, 9/10/11, 10/11, 12, 16, and 17. For MSH-2, products lacking exons 5, 12, 2 through 7: and 2 through 8 were identified. The levels of expression were found to vary among different samples. All isoforms were found in a relevant fraction (43-100%) of the mononuclear blood cell samples, as well as in other tissues. The splicing variants were also detected in normal colonic mucosa, with the exceptions of the MLH1 -6/9 and -10/11 and the MSH2 -13 isoforms. Germline mutations of MLH1 and MSH2 confer constitutional predisposition to the development of colorectal cancer and other neoplasms. A substantial proportion of the mutations identified so far involve alterations of the normal splicing process. Knowledge of the existence of multiple alternative splicing events, not caused by genomic DNA changes, is important for the evaluation of the results of molecular diagnostic tests based on RNA analysis.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalHuman Genetics
Volume102
Issue number1
DOIs
Publication statusPublished - 1998

Fingerprint

Alternative Splicing
Colorectal Neoplasms
Protein Isoforms
Exons
Blood Cells
Mucous Membrane
Melanocyte-Stimulating Hormones
DNA Mismatch Repair
Molecular Pathology
Germ-Line Mutation
Blood Donors
Human Herpesvirus 4
Ileum
Routine Diagnostic Tests
Colonic Neoplasms
Thymus Gland
Genes
Reverse Transcription
Neoplasms
Breast

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. / Genuardi, Maurizio; Viel, Alessaffdra; Bonora, Daniela; Capozzi, Eugenia; Bellacosa, Alfonso; Leonardi, Francesca; Valle, Roberta; Ventura, Andrea; Pedroni, Monica; Boiocchi, Mauro; Neri, Giovanni.

In: Human Genetics, Vol. 102, No. 1, 1998, p. 15-20.

Research output: Contribution to journalArticle

Genuardi, M, Viel, A, Bonora, D, Capozzi, E, Bellacosa, A, Leonardi, F, Valle, R, Ventura, A, Pedroni, M, Boiocchi, M & Neri, G 1998, 'Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility', Human Genetics, vol. 102, no. 1, pp. 15-20. https://doi.org/10.1007/s004390050648
Genuardi, Maurizio ; Viel, Alessaffdra ; Bonora, Daniela ; Capozzi, Eugenia ; Bellacosa, Alfonso ; Leonardi, Francesca ; Valle, Roberta ; Ventura, Andrea ; Pedroni, Monica ; Boiocchi, Mauro ; Neri, Giovanni. / Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. In: Human Genetics. 1998 ; Vol. 102, No. 1. pp. 15-20.
@article{bec0acd3b24e409bb1dbd1593536d053,
title = "Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility",
abstract = "The phenomenon of alternative splicing in the DNA mismatch repair genes MLH1 and MSH2 was extensively investigated by coupled reverse transcription-polymerase chain reaction in different human tissues, including 42 mononuclear blood cell samples - 31 obtained from familial colon cancer patients or their at-risk relatives and 11 from healthy blood donors - 7 normal colonic mucosae, 4 established human cancer cell lines, 8 colorectal tumors, and one sample each of ileum, liver, muscle, thymus, breast, and EBV-transformed lymphoblasts. Several isoforms were observed for each gene. Products of MLH1 alternative splicing included mRNAs lacking alternative exons 6/9, 9, 9/10, 9/10/11, 10/11, 12, 16, and 17. For MSH-2, products lacking exons 5, 12, 2 through 7: and 2 through 8 were identified. The levels of expression were found to vary among different samples. All isoforms were found in a relevant fraction (43-100{\%}) of the mononuclear blood cell samples, as well as in other tissues. The splicing variants were also detected in normal colonic mucosa, with the exceptions of the MLH1 -6/9 and -10/11 and the MSH2 -13 isoforms. Germline mutations of MLH1 and MSH2 confer constitutional predisposition to the development of colorectal cancer and other neoplasms. A substantial proportion of the mutations identified so far involve alterations of the normal splicing process. Knowledge of the existence of multiple alternative splicing events, not caused by genomic DNA changes, is important for the evaluation of the results of molecular diagnostic tests based on RNA analysis.",
author = "Maurizio Genuardi and Alessaffdra Viel and Daniela Bonora and Eugenia Capozzi and Alfonso Bellacosa and Francesca Leonardi and Roberta Valle and Andrea Ventura and Monica Pedroni and Mauro Boiocchi and Giovanni Neri",
year = "1998",
doi = "10.1007/s004390050648",
language = "English",
volume = "102",
pages = "15--20",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility

AU - Genuardi, Maurizio

AU - Viel, Alessaffdra

AU - Bonora, Daniela

AU - Capozzi, Eugenia

AU - Bellacosa, Alfonso

AU - Leonardi, Francesca

AU - Valle, Roberta

AU - Ventura, Andrea

AU - Pedroni, Monica

AU - Boiocchi, Mauro

AU - Neri, Giovanni

PY - 1998

Y1 - 1998

N2 - The phenomenon of alternative splicing in the DNA mismatch repair genes MLH1 and MSH2 was extensively investigated by coupled reverse transcription-polymerase chain reaction in different human tissues, including 42 mononuclear blood cell samples - 31 obtained from familial colon cancer patients or their at-risk relatives and 11 from healthy blood donors - 7 normal colonic mucosae, 4 established human cancer cell lines, 8 colorectal tumors, and one sample each of ileum, liver, muscle, thymus, breast, and EBV-transformed lymphoblasts. Several isoforms were observed for each gene. Products of MLH1 alternative splicing included mRNAs lacking alternative exons 6/9, 9, 9/10, 9/10/11, 10/11, 12, 16, and 17. For MSH-2, products lacking exons 5, 12, 2 through 7: and 2 through 8 were identified. The levels of expression were found to vary among different samples. All isoforms were found in a relevant fraction (43-100%) of the mononuclear blood cell samples, as well as in other tissues. The splicing variants were also detected in normal colonic mucosa, with the exceptions of the MLH1 -6/9 and -10/11 and the MSH2 -13 isoforms. Germline mutations of MLH1 and MSH2 confer constitutional predisposition to the development of colorectal cancer and other neoplasms. A substantial proportion of the mutations identified so far involve alterations of the normal splicing process. Knowledge of the existence of multiple alternative splicing events, not caused by genomic DNA changes, is important for the evaluation of the results of molecular diagnostic tests based on RNA analysis.

AB - The phenomenon of alternative splicing in the DNA mismatch repair genes MLH1 and MSH2 was extensively investigated by coupled reverse transcription-polymerase chain reaction in different human tissues, including 42 mononuclear blood cell samples - 31 obtained from familial colon cancer patients or their at-risk relatives and 11 from healthy blood donors - 7 normal colonic mucosae, 4 established human cancer cell lines, 8 colorectal tumors, and one sample each of ileum, liver, muscle, thymus, breast, and EBV-transformed lymphoblasts. Several isoforms were observed for each gene. Products of MLH1 alternative splicing included mRNAs lacking alternative exons 6/9, 9, 9/10, 9/10/11, 10/11, 12, 16, and 17. For MSH-2, products lacking exons 5, 12, 2 through 7: and 2 through 8 were identified. The levels of expression were found to vary among different samples. All isoforms were found in a relevant fraction (43-100%) of the mononuclear blood cell samples, as well as in other tissues. The splicing variants were also detected in normal colonic mucosa, with the exceptions of the MLH1 -6/9 and -10/11 and the MSH2 -13 isoforms. Germline mutations of MLH1 and MSH2 confer constitutional predisposition to the development of colorectal cancer and other neoplasms. A substantial proportion of the mutations identified so far involve alterations of the normal splicing process. Knowledge of the existence of multiple alternative splicing events, not caused by genomic DNA changes, is important for the evaluation of the results of molecular diagnostic tests based on RNA analysis.

UR - http://www.scopus.com/inward/record.url?scp=0031922771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031922771&partnerID=8YFLogxK

U2 - 10.1007/s004390050648

DO - 10.1007/s004390050648

M3 - Article

C2 - 9490293

AN - SCOPUS:0031922771

VL - 102

SP - 15

EP - 20

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 1

ER -